These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5469312)

  • 21. [Pharmacotherapeutic information explosion and medical practice].
    Dahlström H
    Lakartidningen; 1972 Sep; 69(40):4512-4. PubMed ID: 5072438
    [No Abstract]   [Full Text] [Related]  

  • 22. The goals and functions of a P & T committee.
    Sudds TW; Williams RR
    Hosp Formul; 1985 Nov; 20(11):1163-5, 1171, 1174. PubMed ID: 10274572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug samples in the hospital revisited.
    Lipman AG
    Hosp Formul; 1987 Feb; 22(2):123. PubMed ID: 10280288
    [No Abstract]   [Full Text] [Related]  

  • 24. Written policy needed to limit use of dangerous drugs.
    Bowles GC
    Mod Hosp; 1968 Apr; 110(4):132. PubMed ID: 5644545
    [No Abstract]   [Full Text] [Related]  

  • 25. Editorial: Solving problems associated with large-volume parenterals, II: A hospital surveillance and reporting system.
    Zellmer WA
    Am J Hosp Pharm; 1975 Dec; 32(12):1231. PubMed ID: 1211394
    [No Abstract]   [Full Text] [Related]  

  • 26. [What should embrace a national therapeutic drug strategy?].
    Furängen A; Cronlund A
    Lakartidningen; 2010 Jun 2-8; 107(22):1486-7; discussion 1487. PubMed ID: 20645603
    [No Abstract]   [Full Text] [Related]  

  • 27. The other side of the fence: hospital P&T committee members' role in drug selection.
    Archambault GF
    Med Mark Media; 1978 May; 13(5):48, 50, 52 passim. PubMed ID: 10307029
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmaceutical economics and socialistic organization. 19. Needs and demands of the drug internal market].
    Seidlein HJ
    Pharm Prax; 1970; 11():241-7. PubMed ID: 5494136
    [No Abstract]   [Full Text] [Related]  

  • 29. [Compendium medicamentorum].
    Buriánek J; Hubík J; Parrák V
    Cesk Farm; 1972 Oct; 21(8):337-40. PubMed ID: 5084368
    [No Abstract]   [Full Text] [Related]  

  • 30. [Round table discussion on the Scandinavian drug market: A common pharmacy and therapeutics committee is proposed in view of threats from abroad of lowered standards].
    Nord Med; 1974 Jan; 89(1):3-5. PubMed ID: 4856475
    [No Abstract]   [Full Text] [Related]  

  • 31. [Drug supply chain safety in hospitals: current data and experience of the Grenoble university hospital].
    Bedouch P; Baudrant M; Detavernier M; Rey C; Brudieu E; Foroni L; Allenet B; Calop J
    Ann Pharm Fr; 2009 Jan; 67(1):3-15. PubMed ID: 19152845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mission, role, and functions of the P & T Committee.
    Bell JE; Evans PJ; Standish RC
    Hosp Formul; 1983 Jun; 18(6):639-40, 643-6. PubMed ID: 10260202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [24th Report on the regular meeting of the Central Expert Committee for the drug trade (ZGA) on September 24, 1965 including the meeting of the Governing Body on June 30 and September 2, 1965].
    Pharm Prax; 1966; 10():235-8. PubMed ID: 6001098
    [No Abstract]   [Full Text] [Related]  

  • 34. [The drug committee--an educational police?].
    Carlsson T; Nemeczek C
    Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2421-2; discussion 2422. PubMed ID: 16184900
    [No Abstract]   [Full Text] [Related]  

  • 35. How to crack the $2 billion hospital market for pharmaceuticals.
    Zellmer WA
    Med Mark Media; 1981 May; 16(5):16, 24. PubMed ID: 10251527
    [No Abstract]   [Full Text] [Related]  

  • 36. IV push policy: the economic effects of IV drug administration guidelines.
    Hughes TE; Suzuki NT
    Hosp Formul; 1986 Jul; 21(7):793-9, 802. PubMed ID: 10317755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Standardization as a basis planning and administration in drug industry and pharmacy (II)].
    Wagler M
    Pharm Prax; 1970; 7():151-3. PubMed ID: 5469874
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug committee--an educational police?].
    Carlsson T; Nemeczek C
    Lakartidningen; 2005 Aug 22-28; 102(34):2327-8; discussion 2238. PubMed ID: 16167633
    [No Abstract]   [Full Text] [Related]  

  • 39. [Standardization as a basis for planning and administration in drug industry and pharmacy (I)].
    Koch H
    Pharm Prax; 1970; 7():147-51. PubMed ID: 5469873
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of drug and therapeutics committee towards drug safety--experiences from western Nepal.
    Palaian S; Mishra P
    Kathmandu Univ Med J (KUMJ); 2005; 3(1):79-80. PubMed ID: 16401950
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.